Back to Journals » Clinical Ophthalmology » Volume 16

Active Pharmacovigilance in Peruvian Population: Surveillance of a Timolol/Brimonidine/Dorzolamide Ophthalmic Fixed Combination [Erratum]

Authors Contreras-Salinas H , Barajas-Hernández M , Baiza-Durán LM, Vázquez-Álvarez AO, Bautista-Castro MA, Rodríguez-Herrera LY 

Received 24 January 2022

Accepted for publication 24 January 2022

Published 4 February 2022 Volume 2022:16 Pages 245—246

DOI https://doi.org/10.2147/OPTH.S359723



Contreras-Salinas H, Barajas-Hernández M, Baiza-Durán LM, Vázquez-Álvarez AO, Bautista-Castro MA, Rodríguez-Herrera LY. Clin Ophthalmol. 2021;15:583–590.

On page 587, Table 3 was distorted during the correction stage and published in error. The correct Table 3 is shown in Download Article.

Table 3 ADRs of TBD vs Reported by Individual Active Ingredient

This error was introduced by the typesetting team during the editing process and was not picked up before publication.

Read the original article

Creative Commons License © 2022 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.